ZEAL - Zealand Pharma A/S

Healthcare - Sector
Coverage

with average potential upside of $4.84 (19.01%) backed by 15 price targets and 12 ratings. Analyst's average stock valuation to be materialised ratio is 83.33% with an average time for price targets to be met of 145 days.

Most recent stock forecast was given by DAVID LEBOWITZ from CITI on 13-Nov-2020.

Best performing analysts who are covering ZEAL - Zealand Pharma A/S:

David Lebowitz

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

44

$26.41 (150.14%)

45

2 years 2 months 24 days ago

10/12 (83.33%)

$4.84 (19.01%)

145

Show more analysts